Ron T Gansevoort Selected Research

Chronic Pain

1/2023	Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease.
1/2017	Novel treatment protocol for ameliorating refractory, chronic pain in patients with autosomal dominant polycystic kidney disease.
6/2014	Chronic kidney pain in autosomal dominant polycystic kidney disease: a case report of successful treatment by catheter-based renal denervation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ron T Gansevoort Research Topics

Disease

86	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2024 - 06/2010
59	Chronic Renal Insufficiency 12/2023 - 02/2006
57	Albuminuria 12/2023 - 05/2005
37	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 11/2006
28	Heart Failure 05/2024 - 01/2010
28	Hypertension (High Blood Pressure) 12/2023 - 01/2012
26	Disease Progression 12/2023 - 06/2012
25	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2005
23	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2006
22	Kidney Diseases (Kidney Disease) 01/2023 - 03/2009
21	Inflammation (Inflammations) 05/2024 - 01/2007
18	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2006
17	COVID-19 01/2024 - 01/2020
16	Renal Insufficiency (Renal Failure) 01/2024 - 11/2004
15	Cysts 05/2023 - 05/2011
12	Obesity 01/2023 - 01/2007
10	Polycystic Kidney Diseases (Polycystic Kidney Disease) 02/2024 - 05/2011
10	Pain (Aches) 12/2023 - 12/2012
10	Proteinuria 11/2023 - 01/2007
9	Myocardial Infarction 02/2024 - 02/2012
9	Insulin Resistance 01/2023 - 10/2005
8	Neoplasms (Cancer) 03/2024 - 05/2009
8	Stroke (Strokes) 02/2024 - 02/2012
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2023 - 10/2005
7	Atherosclerosis 01/2023 - 01/2007
7	Infections 01/2023 - 01/2017
6	Acute Kidney Injury (Acute Renal Failure) 10/2023 - 12/2014
5	Polycystic liver disease 05/2023 - 03/2014
5	Fibrosis (Cirrhosis) 01/2017 - 01/2012
4	Peripheral Arterial Disease 10/2023 - 06/2014
4	Coronary Disease (Coronary Heart Disease) 10/2023 - 11/2005
4	Atrial Fibrillation 10/2023 - 05/2013
4	Body Weight (Weight, Body) 07/2021 - 05/2011
3	Polyuria 10/2023 - 01/2018
3	Chronic Pain 01/2023 - 06/2014

Drug/Important Bio-Agent (IBA)

64	CreatinineIBA 03/2024 - 05/2005
56	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2006
54	AlbuminsIBA 03/2024 - 11/2004
30	Tolvaptan FDA Link 02/2024 - 05/2011
20	Vasopressins (Vasopressin)IBA 02/2024 - 08/2009
18	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2008
17	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 07/2022 - 05/2011
16	SodiumIBA 01/2022 - 06/2012
14	Cystatin CIBA 10/2023 - 02/2010
13	C-Reactive ProteinIBA 05/2024 - 05/2005
13	Antihypertensive Agents (Antihypertensives)IBA 12/2023 - 01/2006
13	TEMPOIBA 01/2022 - 05/2011
12	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2005
11	PotassiumIBA 01/2022 - 06/2013
9	LipidsIBA 01/2020 - 07/2010
8	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 02/2006
8	HDL CholesterolIBA 11/2013 - 05/2009
7	MagnesiumIBA 08/2023 - 06/2013
6	Immunoglobulin G (IgG)IBA 01/2024 - 01/2007
6	SaltsIBA 10/2023 - 10/2013
6	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 05/2009
6	CholesterolIBA 01/2022 - 12/2012
6	lanreotide (Somatuline)FDA Link 06/2021 - 03/2014
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2021 - 03/2014
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2006
5	Troponin T (Troponin T1)IBA 05/2024 - 09/2012
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024 - 01/2018
5	Fibroblast Growth Factor-23IBA 11/2023 - 11/2019
5	COVID-19 VaccinesIBA 03/2023 - 01/2021
5	Natriuretic PeptidesIBA 01/2023 - 02/2006
5	Edetic Acid (EDTA)FDA Link 12/2021 - 02/2012
5	Uric Acid (Urate)IBA 10/2019 - 01/2012
5	Arginine Vasopressin (Argipressin)IBA 01/2017 - 03/2013
4	2019-nCoV Vaccine mRNA-1273IBA 05/2023 - 01/2021
4	Peptides (Polypeptides)IBA 05/2023 - 02/2006
4	Lipocalin-2IBA 01/2023 - 04/2011
4	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 01/2020
4	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2006
4	dapagliflozinIBA 01/2021 - 01/2018
4	Urea (Carbamide)FDA LinkGeneric 01/2021 - 09/2014
4	Losartan (Cozaar)FDA LinkGeneric 01/2017 - 01/2006
4	Triglycerides (Triacylglycerol)IBA 07/2016 - 10/2005
4	ApolipoproteinsIBA 07/2016 - 07/2012
4	Insulin (Novolin)FDA Link 09/2015 - 10/2005
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2024 - 12/2023
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 02/2024 - 01/2018
3	AntibodiesIBA 01/2024 - 10/2022
3	Analgesics (Analgesic Drugs)IBA 12/2023 - 01/2018
3	SeleniumIBA 12/2023 - 01/2022
3	AtrasentanIBA 12/2023 - 12/2021
3	CytokinesIBA 05/2023 - 03/2016
3	LigandsIBA 01/2023 - 10/2015
3	Epidermal Growth Factor (EGF)IBA 01/2023 - 10/2015
3	Erythropoietin FDA Link 01/2023 - 01/2015
3	TOR Serine-Threonine KinasesIBA 11/2022 - 05/2011
3	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 01/2021

Therapy/Procedure

24	Therapeutics 12/2023 - 01/2006
16	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2023 - 09/2014
10	Transplantation 10/2023 - 01/2006
9	Kidney Transplantation 02/2024 - 01/2007
9	Renal Dialysis (Hemodialysis) 04/2023 - 01/2005
6	Nephrectomy 04/2023 - 07/2016
4	Denervation 01/2018 - 06/2014
4	Catheters 01/2018 - 06/2014
3	Aftercare (After-Treatment) 01/2023 - 10/2015